Alyce Katayama
Professional Bio
Alyce Katayama had more than 30 years of experience representing both institutional and individual clients on a wide range of business issues in the health care industry. She dealt regularly with issues surrounding the 340B Drug Discount Program and the Sunshine Act.
The Omnibus Guidance is Dead!
To Be or Not to 340B Blog ·
Key Takeaway from 340B Conferences – Audits
To Be or Not to 340B Blog ·
Comparing 340B University and the 340B Coalition Conference
To Be or Not to 340B Blog ·
Top Takeaway from 340B University and 340B Coalition Conference
To Be or Not to 340B Blog ·
Site Neutral Payments Put 340B Child Sites in Jeopardy
To Be or Not to 340B Blog ·